Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Align Technology Inc Stock Research

ALGN

301.67USD-7.83(-2.53%)Delayedas of 21 Sep 2023, 12:16 pm
Watchlist

Market Summary

USD301.67-7.83
Delayedas of 21 Sep 2023, 12:16 pm
-2.53%

ALGN Stock Price

ALGN RSI Chart

ALGN Valuation

Market Cap

23.7B

Price/Earnings (Trailing)

75.41

Price/Sales (Trailing)

6.34

EV/EBITDA

33.35

Price/Free Cashflow

38.73

ALGN Price/Sales (Trailing)

ALGN Profitability

Operating Margin

69.78%

EBT Margin

14.74%

Return on Equity

9.05%

Return on Assets

5.34%

Free Cashflow Yield

2.58%

ALGN Fundamentals

ALGN Revenue

Revenue (TTM)

3.7B

Revenue Y/Y

3.36%

Revenue Q/Q

6.26%

ALGN Earnings

Earnings (TTM)

314.1M

Earnings Y/Y

-0.87%

Earnings Q/Q

27.35%

Price Action

52 Week Range

172.05413.20
(Low)(High)

Last 7 days

-4%

Last 30 days

-9.7%

Last 90 days

-7.4%

Trailing 12 Months

33.3%

ALGN Financial Health

Current Ratio

1.16

ALGN Investor Care

Buy Backs (1Y)

2.38%

Diluted EPS (TTM)

4.07

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for ALGN

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-07-20
Coletti Julie Ann
sold (taxes)
-49,648
330
-150
evp, chief legal & regulatory
2023-07-20
Coletti Julie Ann
acquired
-
-
320
evp, chief legal & regulatory
2023-05-30
MORROW GEORGE J
gifted
-
-
-10,000
-
2023-05-30
Dallas Kevin J
bought
1,996,800
285
7,000
-
2023-05-17
Dallas Kevin J
acquired
-
-
1,114
-
2023-05-17
LACOB JOSEPH
acquired
-
-
1,114
-
2023-05-17
Myong Anne
acquired
-
-
1,114
-
2023-05-17
Thaler Warren S
acquired
-
-
1,114
-
2023-05-17
SIEGEL SUSAN E
sold
-
-
-1,114
-
2023-05-17
SANTORA GREG J
acquired
-
-
1,114
-

1–10 of 50

Which funds bought or sold ALGN recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-12
Farther Finance Advisors, LLC
added
103
42,833
79,923
0.02%
2023-09-07
ST GERMAIN D J CO INC
new
-
44,205
44,205
-%
2023-09-07
JAG CAPITAL MANAGEMENT, LLC
unchanged
-
23,556
427,197
0.05%
2023-09-01
Portside Wealth Group, LLC
new
-
1,673,070
1,673,070
0.31%
2023-08-29
EFG Asset Management (Americas) Corp.
added
3.8
37,261
415,173
0.10%
2023-08-25
Brown Shipley& Co Ltd
new
-
7,780
7,780
-%
2023-08-25
Yarbrough Capital, LLC
unchanged
-
16,263
294,936
0.02%
2023-08-24
Alberta Investment Management Corp
unchanged
-
995,787
18,059,000
0.17%
2023-08-23
Stonebridge Capital Advisors LLC
unchanged
-
1,365
24,755
-%
2023-08-22
Asset Dedication, LLC
unchanged
-
-
4,000
-%

1–10 of 46

Latest Funds Activity

Are funds buying ALGN calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own ALGN
No. of Funds

Schedule 13G FIlings of Align Tech

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
edgewood management llc
4.4%
3,409,145
SC 13G/A
Feb 09, 2023
vanguard group inc
10.66%
8,329,757
SC 13G/A
Feb 01, 2023
gund gordon
1.4%
1,073,738
SC 13G/A
Jan 31, 2023
blackrock inc.
7.1%
5,555,607
SC 13G/A
Feb 14, 2022
edgewood management llc
5.6%
4,385,581
SC 13G/A
Feb 09, 2022
vanguard group inc
7.45%
5,871,579
SC 13G/A
Feb 07, 2022
gund gordon
1.4%
1,085,188
SC 13G/A
Feb 03, 2022
blackrock inc.
7.3%
5,743,160
SC 13G/A
Feb 16, 2021
edgewood management llc
5.9%
4,613,620
SC 13G/A
Feb 11, 2021
gund gordon
1.5%
1,171,411
SC 13G/A

Recent SEC filings of Align Tech

View All Filings
Date Filed Form Type Document
Sep 06, 2023
8-K
Current Report
Aug 24, 2023
8-K
Current Report
Aug 04, 2023
S-8
Employee Benefits Plan
Aug 04, 2023
10-Q
Quarterly Report
Jul 26, 2023
8-K
Current Report
Jul 24, 2023
4
Insider Trading

ALGN Fair Value

Loading...

Peers (Alternatives to Align Tech)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
109.7B
19.5B
4.61% 32.58%
40.5
5.64
10.36% 30.30%
108.4B
31.6B
-0.16% -7.89%
29.89
3.44
1.57% -30.40%
102.6B
6.7B
1.85% 46.31%
71.98
15.39
11.75% -0.66%
71.3B
19.0B
-3.08% 10.26%
44.09
3.79
0.46% -5.24%
43.7B
5.7B
-5.74% -17.48%
31.48
7.73
5.64% -4.53%
MID-CAP
10.1B
937.8M
5.52% 36.72%
345.25
10.72
16.30% 250.21%
7.5B
616.6M
-7.14% -29.65%
30.68
12.13
69.52% 343.68%
5.3B
1.1B
-4.57% -12.56%
25.23
4.84
12.63% 50.85%
2.7B
452.1M
-16.85% -42.51%
-27.51
6.04
24.99% 24.09%
1.5B
790.3M
-18.06% -57.30%
-6.6
1.87
3.21% -1604.53%
SMALL-CAP
952.1M
780.7M
-7.00% -11.88%
-26.45
1.22
4.68% -510.17%
839.3M
239.8M
0.70% 0.15%
-22.16
3.5
-4.74% -31.15%
620.2M
162.9M
-26.12% -63.06%
-11.73
3.81
42.67% 12.82%
551.7M
162.2M
16.09% -48.52%
-6.56
3.4
9.71% 12.37%

Align Tech News

Express Healthcare Management
Analysts Weigh In on PTC Therapeutics, Align Tech, and Globus ....
Express Healthcare Management,
3 days ago
Investor's Business Daily
Investor's Business Daily
Marketscreener.com

Returns for ALGN

Cumulative Returns on ALGN

20.6%


10-Year Cumulative Returns

18.3%


7-Year Cumulative Returns

-4.1%


5-Year Cumulative Returns

-1.2%


3-Year Cumulative Returns

Risks for ALGN

What is the probability of a big loss on ALGN?

82.7%


Probability that Align Tech stock will be more than 20% underwater in next one year

80.8%


Probability that Align Tech stock will be more than 30% underwater in next one year.

69.6%


Probability that Align Tech stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does ALGN drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Align Tech was unfortunately bought at previous high price.

Drawdowns

Financials for Align Tech

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue0.9%3,7373,7053,7353,8643,9904,0313,9533,7933,5122,8532,4722,2872,1602,4092,4072,2912,1892,0791,9661,8541,734
Cost Of Revenue0.6%1,1261,1191,1011,1041,0931,0631,017955894770709662632673663636600556519471430
Gross Profit1.0%2,6112,5852,6342,7612,8972,9682,9352,8012,5802,0461,7631,6251,5281,7361,7441,6551,5891,5231,4481,3831,303
Operating Expenses2.1%2,0492,0071,9912,0102,0282,0191,9591,8331,6961,5031,3761,3001,2531,2111,2011,1431,0791,066981927874
  S&GA Expenses1.6%1,7011,6751,6741,7161,7451,7511,7091,6061,4901,3151,2011,1321,0971,1081,0721,019956900852808763
  R&D Expenses4.8%336321305294283268250227206188175168163161157152145137129119111
EBITDA-100.0%-6787258259601,0511,1211,0971,017686473411350617642------
EBITDA Margin-100.0%-0.18*0.19*0.21*0.24*0.26*0.28*0.29*0.29*0.24*0.19*0.18*0.16*0.26*0.27*------
Earnings Before Taxes-0.4%5445465997048439381,0121,007930587379320264531563529527451467457433
EBT Margin-100.0%-0.15*0.16*0.18*0.21*0.23*0.26*0.27*0.27*0.21*0.15*0.14*0.12*0.22*0.23*------
Net Income-0.3%3143153625116197067727406984581,7761,7381,7011,889443419417376400313295
Net Income Margin-100.0%-0.09*0.10*0.13*0.16*0.18*0.20*0.20*0.20*0.16*0.72*0.76*0.79*0.78*0.18*------
Free Cashflow-100.0%-469277349389531771936895727507373391497616------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets4.1%6,1455,9015,9485,9135,8105,9435,9425,6505,3965,0704,8304,4154,0263,9652,5012,3502,3462,2342,0521,9281,917
  Current Assets5.7%2,4652,3322,4242,5012,3772,4812,4942,4552,2322,1161,8501,4731,1491,5771,6331,5061,4571,4391,3021,2241,261
    Cash Equivalents14.4%9528329421,0458789271,1001,2381,0871,132961616405791551491424589638421549
  Inventory0.3%31331233932131027623020717915113912313112111295.0081.0068.0056.0049.0047.00
  Net PPE1.3%1,2791,2631,2321,2001,1821,1411,0821,003961764735704669663632607600575521492448
  Goodwill0.1%415414408378390412419427432428445--34064.00---64.00--
Liabilities3.5%2,5062,4212,3472,2182,2112,2772,3192,1332,0111,6761,5961,3821,1811,1121,1551,045972979800735698
  Current Liabilities5.1%2,1072,0051,9261,8091,8041,8641,9241,7901,6971,3941,3261,122942911971870789805692618567
Shareholder's Equity4.5%3,6383,4803,6013,6953,5993,6673,6233,5173,3843,3943,2343,0332,8452,8531,3461,3061,3741,2561,2531,1931,219
  Retained Earnings4.7%2,4852,3742,5672,6752,6022,6802,6192,5272,4592,4162,2162,0571,9171,958440415501402378328373
  Additional Paid-In Capital3.3%1,1421,1051,0451,0611,017992999972896948975952918895907892874856878865845
Shares Outstanding0.0%77.0077.0077.0078.0078.0079.0079.0079.0079.0079.0079.0079.0079.0079.0078.0079.0080.0080.0080.0080.0080.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations16.9%8637385696977859761,1731,2811,137880662499522640747770632595555476498
  Share Based Compensation2.7%14313913312912411911411010710398.0094.0093.0090.0088.0087.0082.0076.0071.0067.0063.00
Cashflow From Investing-81.6%-319-175-213-465-511-658-563-300-183-503-231-246-2010.00-350-259-368-1767.00-43.71-85.76
Cashflow From Financing30.8%-449-648-501-403-478-516-458-359-286-49.51-30.81-130-333-427-485-437-387-322-369-371-222
  Buy Backs-30.7%452652435375490450375275160--100300350400350300250300300165

ALGN Income Statement

2023-06-30
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]    
Net revenues$ 1,002,173$ 969,553$ 1,945,320$ 1,942,772
Cost of net revenues288,564281,994571,057545,867
Gross profit713,609687,5591,374,2631,396,905
Operating expenses:    
Selling, general and administrative453,193426,398892,884865,855
Research and development88,48572,965175,932144,772
Total operating expenses541,678499,3631,068,8161,010,627
Income from operations171,931188,196305,447386,278
Interest income4,4212456,758922
Other income (expense), net(4,763)(14,832)(5,992)(26,105)
Total interest income and other income (expense), net(342)(14,587)766(25,183)
Net income before provision for income taxes171,589173,609306,213361,095
Provision for income taxes59,77560,809106,601113,997
Net income$ 111,814$ 112,800$ 199,612$ 247,098
Net income per share:    
Basic (in usd per share)$ 1.46$ 1.44$ 2.60$ 3.15
Diluted (in usd per share)$ 1.46$ 1.44$ 2.60$ 3.13
Shares used in computing net income per share:    
Basic (in shares)76,52478,39576,72278,568
Diluted (in shares)76,68978,54576,89778,840

ALGN Balance Sheet

2023-06-30
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 951,956$ 942,050
Marketable securities, short-term55,80557,534
Accounts receivable, net of allowance for doubtful accounts of $13,244 and $10,343, respectively908,395859,685
Inventories312,736338,752
Prepaid expenses and other current assets236,564226,370
Total current assets2,465,4562,424,391
Marketable securities, long-term26,02341,978
Property, plant and equipment, net1,279,0421,231,855
Operating lease right-of-use assets, net125,881118,880
Goodwill414,765407,551
Intangible assets, net89,29695,720
Deferred tax assets1,605,9261,571,746
Other assets138,16155,826
Total assets6,144,5505,947,947
Current liabilities:  
Accounts payable110,155127,870
Accrued liabilities600,163454,374
Deferred revenues1,396,7471,343,643
Total current liabilities2,107,0651,925,887
Income tax payable113,309124,393
Operating lease liabilities104,650100,334
Other long-term liabilities181,225195,975
Total liabilities2,506,2492,346,589
Commitments and contingencies (Notes 6 and 7)
Stockholders’ equity:  
Preferred stock, $0.0001 par value (5,000 shares authorized; none issued)00
Common stock, $0.0001 par value (200,000 shares authorized; 76,532 and 77,267 issued and outstanding, respectively)88
Additional paid-in capital1,141,6231,044,946
Accumulated other comprehensive income (loss), net11,343(10,284)
Retained earnings2,485,3272,566,688
Total stockholders’ equity3,638,3013,601,358
Total liabilities and stockholders’ equity$ 6,144,550$ 5,947,947
Joseph M. Hogan
22500
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.